← All Boundless Bio, INC filings

Boundless Bio, INC S-1 registration statements

Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.

NASDAQ
BOLD
Boundless Bio, INC
S-1/A: Boundless Bio Aims to Raise Millions in IPO to Advance Cancer Therapies
Boundless Bio is seeking to raise capital through an IPO to further develop its ecDNA-directed cancer therapies and diagnostic tools.
NASDAQ
BOLD
Boundless Bio, INC
S-1: Boundless Bio Files for Initial Public Offering, Aiming to Revolutionize Cancer Treatment
Boundless Bio, a clinical-stage oncology company, has filed an S-1 registration statement for an IPO, seeking to advance its novel ecDNA-directed therapies for oncogene-amplified cancers.